Connection

Amy Sion to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Amy Sion has written about Antibodies, Monoclonal.
Amy Sion
Connection Strength
0.523
Antibodies, Monoclonal
  1. Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. Semin Oncol. 2018 06; 45(3):156-163.
    View in: PubMed
    Score: 0.523
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.